Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lybalvi
Lybalvi
With good news on Lybalvi, Alkermes sees 10% share price increase
Fierce Pharma
Fri, 02/16/24 - 11:21 am
Alkermes
Lybalvi
schizophrenia
biopolar disorder
After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi
Pharmaforum
Thu, 06/3/21 - 10:37 am
Alkermes
FDA
antipsychotic
Lybalvi
Alkermes prepares for uncertain launch as FDA finally clears schizophrenia drug
Biopharma Dive
Tue, 06/1/21 - 10:37 pm
Alkermes
FDA
schizophrenia
bipolar disorder
Lybalvi